PB2213: EFFECTIVENESS OF CRIZANLIZUMAB IN REDUCING VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE IN BRAZIL: STUDY PROTOCOL FOR AN OBSERVATIONAL, RETROSPECTIVE, MULTICENTER, NATIONAL STUDY

• C. Bueno,
• L. Campos,
• A. Ritter,
• C. Zampirolli,
• R. Watanabe de Oliveira

Affiliations

C. Bueno

1 Novartis

L. Campos

1 Novartis

A. Ritter

2 IQVIA, São Paulo, Brazil

C. Zampirolli

2 IQVIA, São Paulo, Brazil

R. Watanabe de Oliveira

2 IQVIA, São Paulo, Brazil